537 related articles for article (PubMed ID: 10638238)
1. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
2. [Experience in the use of losek (omeprazole) in gastroenterology].
Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
[No Abstract] [Full Text] [Related]
3. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
[No Abstract] [Full Text] [Related]
4. [Lansoprazol].
Ponce J; Nos P
Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
[No Abstract] [Full Text] [Related]
5. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
[No Abstract] [Full Text] [Related]
6. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
Piai G; Sabbatini F; Mazzacca G
Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622
[No Abstract] [Full Text] [Related]
7. Acid pump blockers: what are their current therapeutic roles?
Arens MJ; Dent J
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):95-128. PubMed ID: 8097414
[No Abstract] [Full Text] [Related]
8. [Therapeutic achlorhydria: for which diseases, when and for how long?].
Koop H; Arnold R
Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969
[No Abstract] [Full Text] [Related]
9. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Lanas Arbeloa A; Serrano Aulló MT
Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
[No Abstract] [Full Text] [Related]
10. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
Arnold R
Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
[No Abstract] [Full Text] [Related]
11. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
12. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
13. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Bown RL
Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
[TBL] [Abstract][Full Text] [Related]
14. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
15. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
Bulgakov SA
Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
[No Abstract] [Full Text] [Related]
16. Helicobacter pylori and lanzoprazole.
Stermer E; Levy N
Am J Gastroenterol; 1996 Aug; 91(8):1667-8. PubMed ID: 8759695
[No Abstract] [Full Text] [Related]
17. Clinical utility and safety of omeprazole.
Walan A
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
[TBL] [Abstract][Full Text] [Related]
18. A review of omeprazole use in the treatment of acid-related disorders in children.
Zimmermann AE; Walters JK; Katona BG; Souney PE; Levine D
Clin Ther; 2001 May; 23(5):660-79; discussion 645. PubMed ID: 11394727
[TBL] [Abstract][Full Text] [Related]
19. [What does the H. pylori eradication bring?].
MMW Fortschr Med; 2005 Oct; 147(42):6, 8. PubMed ID: 16281773
[No Abstract] [Full Text] [Related]
20. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
